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A new novel virus called SARS-CoV-2 has expanded into a pandemic in the past several months. The virus is an acute respiratory RNA virus that has symptoms in three clinical 
groups: asymptomatic, suspicious, and COVID-19 positive. The clinical lab testsused for diagnosis are Nasalpharyngeal swabs, with further testing done with sputum or BAL samples. 
Serological samples are collected for diagnosis in deceased patients using RT-PCR. The clinical symptoms usually occur 2 to 14 days after exposure and include fever, dry cough, 
and fatigue. In some cases, symptoms can progress and cause multiple organ failure due to adult respiratory distress syndrome (ARDS). The virus is in the family of coronaviruses 
and has also been identifi ed in lung tissue using transmission electron microscopy. Gross and microscopic lung pathology was examined in fi ve positive cases and four negative 
cases by hematoxylin and eosin (H&E) and Masson’s Trichrome stains. Of the collected, the age range was 28 to 76. The ethnicities were six Caucasians and three minorities, with a 
male to female ratio of 7:2. The salient histology features seen in the study were multifocal to diff use alveolar necrosis, bronchiolar epithelial necrosis, and interstitial mononuclear 
lymphocytic infi ltrates. Other features were perivascular and peribronchiolar lymphoid infi ltrates and marked congestion. Scattered fi broplasia was found in the damaged alveoli and 
the alveolar septae in the more severe cases. These pathologic features are similar to other coronaviruses. 
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Introduction
Since December 2019, the infections disease agent SARS-
CoV-2 has spread across the globe affecting people on every 
continent except Antarctica. In general, the virus can cause 
acute respiratory disease with severe symptoms that can lead 
to death [1-3]. The clinical lab tests used for diagnosis are 
Nasalpharyngeal swabs, with further testing done with sputum 
or BAL samples [4-8]. As of now, COVID-19 has infected over 
4.4 million people worldwide, but this number is increasing 
constantly. The death rate is approximately 2% [1]. Severe 
symptoms causing death is due to severe alveolar and small 
bronchiolar damage with subacute to chronic infl ammation 
[1-3,9]. Recent studies have shown SARS-CoV-2 to have a 
high affi nity for the ACE2 receptor found in ciliated bronchial 
epithelium [10]. The ACE2 receptor triggers a protective effect in 
the bronchial epithelium against ARDS [11]. With this pathway 
compromised by SARS-CoV-2, there is severe damage to the 
bronchiolar epithelium and an increase of ARDS (Figure 1).
 
 
Figure 1: A) Focal interstitial pneumonia characterized by alveolar wall thickening. 
B) Bronchiole epithelial necrosis with hyaline membrane disease. C) Bronchiole 
epithelial necrosis surrounded by peribronchiolar lymphocytic infi ltration and 
marked congestion. D) Large area of marked fi broplasia with focal lymphocytic 
infi ltration and bronchiolar necrosis.
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In this paper, the lung pathology of 5 patients who had 
died from severe COVID-19 symptoms were analyzed along 
with 4 negative COVID-19 cases (Table 1). These samples were 
collected post-mortem, and patients were not seen in the 
clinical setting. The pathology fi ndings from these cases will 
add to the pathogenesis of this novel infectious viral disease. 
Materials and methods
Informed consent and IRB approval was obtained for this 
decedent study. All lung and blood specimens were collected 
from the Marion County Coroner’s Offi ce and private funeral 
homes. These were collected from partial autopsies over the 
period of April 9th to May 7th. The cases collected were deemed 
COVID-19 suspicious or COVID-19 positive based on the medical 
forensic coroner’s decision at the scene of death. All cases were 
then tested by the Indiana Department of Health Lab using a 
CDC approved RT-PCR method and then were classifi ed into 
COVID-19 positive and COVID-19 negative.Of the collected, the 
age range was 28 to 76. The ethnicities were six Caucasians and 
three minorities, with a male to female ratio of 7:2. 
Most COVID-19 patients that died in hospitals in the central 
Indiana area were sent directly to funeral homes. The collected 
cases were found dead in their homes, with one in the nursing 
home. Cases are designated as a coroner’s case based on dying 
in their homes and not in a hospital setting. Therefore, medical 
history is limited and only fragments can be collected from 
next of kin. 
The blood was drawn from the heart using an autopsy needle 
and sent to the Indiana Department of Health Laboratories. 
This testing is required by the state on COVID-19 suspicious 
cases, and the test results were used to classify each patient 
as COVID-19 positive or COVID-19 negative. Next, a four 
centimeter incision was made in the chest between the 4th and 
5th ribs on the right side. A section of lung approximately 3cm 
by 2cm was removed and placed in 10% NBF. 
The fi xation time in 10% NBF was extended to 48 hours 
due to the infectious nature of the disease. Usual fi xation time 
for most tissues is approximately 24 hours. When the tissues 
were fi xed, they were trimmed and placed into tissue cassettes. 
Fourteen tissue cassettes were prepared for each case. The 
tissues were then transferred to 70% ethanol before processing 
into a paraffi n block. Five micron sections were microtomed 
and stained with H&E and Masson’s Trichrome stains. 
Results
Histology from the 5 positive cases revealed multifocal to 
diffuse alveolar necrosis and bronchiolar respiratory epithelial 
necrosis. Interstitial mononuclear infl ammatory infi ltrates, 
mainly lymphocytes, were seen in a multifocal pattern 
throughout the biopsies. Perivascular and peribronchiolar 
lymphoid infi ltrates were also seen throughout the biopsies, 
along with marked congestion. Scattered fi broplasia can also 
be seen in the severe cases, extending into alveolar spaces and 
thickening the alveolar septum (Figure 1a,b,c,d). In one case, 
there was mild hyaline membrane formation and slight micro 
thrombi formations in small pulmonary vasculature. Another 
case was found to have aspiration pneumonia. This was 
characterized by plant fi ber and other foreign material, along 
with numerous neutrophils in the lumen of the bronchioles. 
The 4 negative cases were characterized by diffuse 
pulmonary edema and marked congestion. There was no 
evidence of pneumonia or infl ammation in the airways or 
alveoli. 
Discussion
The lung pathological features of COVID-19 found in this 
paper are similar to SARS, MERS, and a recent published 
COVID-19 clinical case with pathology [1,8,12,13]. Based on 
the consistent fi ndings in these cases, the main pathology 
change seen in all diseases listed above was diffuse alveolar 
damage [12,13]. In addition, this study found a complete loss 
of the tertiary bronchiolar epithelial layers also associated with 
peribronchiolar lymphoid hyperplasia in severe cases. Recent 
studies have shown SARS-CoV-2 to have a high affi nity for the 
ACE2 receptor found in ciliated bronchial epithelium, and when 
induced by SARS-CoV-2 there is an increase of tissue damage 
[10,11].
Pa ent ID Age Decedent Sex Medical History Race Smoking Status COVID- 19 Status Hospital Admi ance, length of stay
1 56 Male Diabetes/Fever Black Yes Con rmed Covid19 N/A
2 46 Male Diabetes/Coughing White Unknown Nega ve Covid19 N/A
3 28 Male Hypertension/Seizures White Marijuana Con rmed Covid19 Discharged From hospital 4/10/2020
4 54 Male Shortness of Breath Black No Nega ve Covid19 N/A
5 34 Male Diabetes/Vomi ng White Unknown Nega ve Covid19 N/A
6 42 Female Asthma/High Blood Pressure White Unknown Nega ve Covid19 In ER approximately 10 min
7 76 Female N/A N/A Unknown Con rmed Covid19 N/A
8 67 Male Shortness of Breath White Unknown Con rmed Covid19 Nursing Home
9 53 Male Flu Symptoms White Unknown Con rmed Covid19 N/A
Pa ent Demographics
Table 1: Patient demographics and COVID-19 test results for the 9 cases analyzed.
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